文献速递肝病消化道肿瘤与早癌

病因特异性肝细胞癌发病率:不同种族和族裔间趋势分化且异质性显著

Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-09-06

基于佛罗里达州癌症登记处14420例肝细胞癌(HCC)病例,链接医院出院和病毒性肝炎数据确定2010至2018年主要病因。HCV仍是男性HCC首要病因,但自2017年起NAFLD成为女性首要病因。HCV-HCC发病率自2015年以来快速下降(每年-9.6%),而ALD-HCC(+6.0%)和NAFLD-HCC(+4.3%)上升(P<.05)。

要点

  • HCV仍是男性HCC首要病因,但自2017年起NAFLD成为女性首要病因。
  • HCV-HCC发病率自2015年以来每年下降9.6%,ALD-HCC每年上升6.0%,NAFLD-HCC每年上升4.3%(P<.05)。
  • 西班牙裔人群ALD-HCC和NAFLD-HCC发病率较高,作者认为可能值得关注。

核心结论

  • 新型直接抗病毒药物影响了HCV-HCC发病率,抵消了ALD-HCC和NAFLD-HCC的显著增加。
  • 西班牙裔人群因ALD-HCC和NAFLD-HCC发病率较高,作者认为可能是一个值得关注的群体。
  • HCC病因差异显著,作者认为可能需要对详细种族-族裔群体采取特定干预措施。

研究设计与样本

  • 研究纳入佛罗里达州癌症登记处全部14420例HCC病例,逐一链接医院出院机构和病毒性肝炎部门数据以确定2010至2018年诊断病例的主要病因。
  • 采用年龄调整发病率(AAIRs)评估病因与详细种族-族裔的交叉情况,并使用Joinpoint回归评估基于诊断年份的病因特异性时间趋势。

主要发现

  • HCV仍是男性HCC首要病因,但自2017年起NAFLD-HCC成为女性首要病因。
  • HCV-HCC的AAIR在美国出生的少数族裔男性中尤其高,包括波多黎各男性(10.9/10万)、非裔美国男性(8.0/10万)和美国出生的墨西哥裔美国男性(7.6/10万)。
  • NAFLD在所有西班牙裔和菲律宾人中更常见,HBV-HCC在亚洲和海地黑人男性中更常见。
  • HCV-HCC在亚洲女性中超过HBV-HCC。
  • ALD-HCC在特定西班牙裔男性群体中较高。

关键数值与推荐

  • HCV-HCC基于人群的发病率自2015年以来快速下降(每年-9.6%),而ALD-HCC(+6.0%)和NAFLD-HCC(+4.3%)上升(P<.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The main causes of hepatocellular carcinoma (HCC) include chronic hepatitis C and B viral infections (HCV, HBV), nonalcoholic fatty liver disease (NAFLD), and alcohol-related disease (ALD). Etiology-specific HCC incidence rates and temporal trends on a population-basis are needed to improve HCC control and prevention. METHODS: All 14,420 HCC cases from the Florida statewide cancer registry were individually linked to data from the hospital discharge agency and the viral hepatitis department to determine the predominant etiology of each case diagnosed during 2010 to 2018. Age-adjusted incidence rates (AAIRs) were used to assess the intersection between etiology and detailed race-ethnicity. Etiology-specific temporal trends based on diagnosis year were assessed using Joinpoint regression. RESULTS: HCV remains the leading cause of HCC among men, but since 2017 NAFLD-HCC is the leading cause among women. HCV-HCC AAIRs are particularly high among U.S.-born minority men, including Puerto Rican (10.9 per 100,000), African American (8.0 per 100,000), and U.S.-born Mexican American men (7.6 per 100,000). NAFLD is more common among all Hispanics and Filipinos and HBV-HCC among Asian and Haitian black men. HCV-HCC surpasses HBV-HCC in Asian women. ALD-HCC is high among specific Hispanic male groups. Population-based HCV-HCC rates experienced a rapid decline since 2015 (-9.6% annually), whereas ALD-HCC (+6.0%) and NAFLD-HCC (+4.3%) are rising (P < .05). CONCLUSIONS: New direct acting anti-viral drugs have impacted rates of HCV-HCC, offsetting important increases in both ALD- and NAFLD-HCC. Hispanics may be a group of concern because of higher rates for ALD- and NAFLD-HCC. HCC etiology varies remarkably and may warrant specific interventions by detailed race-ethnicity.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Pinheiro PS, Jones PD, Medina H, et al. Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity. Clin Gastroenterol Hepatol. 2023. PMID: 37678486. doi:10.1016/j.cgh.2023.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。